Effect of type 2 diabetes on the dynamic response characteristics of leg vascular conductance during exercise [0.03%]
2型糖尿病对运动时下肢血管阻力动态反应特征的影响研究
Oscar MacAnaney,Heather Reilly,Donal O&#x;Shea et al.
Oscar MacAnaney et al.
In this study we tested the hypothesis that type 2 diabetes impairs the dynamic response of leg vascular conductance (LVC) during exercise. LVC (leg blood flow/mean arterial pressure) responses were studied during intermittent contractions ...
Preclinical arterial disease in patients with type 1 diabetes without other major cardiovascular risk factors or micro-/ macrovascular disease [0.03%]
无其他主要心血管风险因素或微/巨血管疾病的1型糖尿病患者的临床前动脉疾病
Marga Giménez,Rosa Gilabert,Mercè Lara et al.
Marga Giménez et al.
We aimed to investigate preclinical atherosclerosis in T1D and its relationship with glucose profile and endothelial/ inflammatory markers. Thirty-eight T1D patients without additional cardiovascular risk factors or micro-/macrovascular com...
What drives thrombogenesis despite antiplatelet therapy in diabetes mellitus? [0.03%]
糖尿病患者在接受抗血小板治疗的情况下，为何仍存在促血栓形成？
Robert F Storey
Robert F Storey
Differential adipogenic and inflammatory properties of small adipocytes in Zucker Obese and Lean rats [0.03%]
Zucker肥胖大鼠和正常大鼠的小脂肪细胞具有不同的成脂作用和促炎作用
Alice Liu,Alper Sonmez,Gail Yee et al.
Alice Liu et al.
We recently reported that a preponderance of small adipose cells, decreased expression of cell differentiation markers, and enhanced inflammatory activity in human subcutaneous whole adipose tissue were associated with insulin resistance. T...
DIRECT study: a commentary [0.03%]
DIRECT研究述评
Mark E Cooper
Mark E Cooper
Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease [0.03%]
糖尿病合并冠心病患者的抗栓治疗
José Luis Ferreiro,Ángel R Cequier,Dominick J Angiolillo
José Luis Ferreiro
Currently approved antiplatelet treatment strategies have proved successful for reducing cardiovascular adverse events in patients with CAD. However, despite the use of recommended antiplatelet treatment strategies, the presence of DM has b...
José Luis Ferreiro,Joan Antoni Gómez-Hospital,Dominick J Angiolillo
José Luis Ferreiro
Patients with diabetes mellitus (DM) have accelerated atherosclerosis, which is the main underlying factor contributing to the high risk of atherothrombotic events in these patients. Atherothrombotic complications are the leading cause of m...
Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes [0.03%]
代谢综合征和他汀治疗及非他汀治疗的2型糖尿病中的小而密LDL和LDL糖基化
Nahla N Younis,Handrean Soran,Reena Sharma et al.
Nahla N Younis et al.
Small-dense LDL (SD-LDL) has been particularly implicated in atherosclerosis. It has previously been reported that in non-diabetic people SD-LDL is preferentially glycated. The distribution of glycated apolipoprotein B (glyc-apoB) in lipopr...
S H Alzahrani,R A Ajjan
S H Alzahrani
Atherothrombotic complications are the main cause of mortality in subjects with diabetes. Premature atherosclerosis, increased platelet reactivity and activation of coagulation factors with associated hypofibrinolysis all contribute to incr...
Effects of admission serum urea, glomerular filtration rate, proteinuria and diabetes status on 3-month mortality after acute stroke [0.03%]
入院时血清尿素、肾小球滤过率、蛋白尿和糖尿病状态对急性脑卒中后3个月死亡率的影响
Iskandar Idris,Robert Hill,Jagdish C Sharma
Iskandar Idris